We continue to develop resources related to the COVID-19 pandemic. See COVID-19 initiatives on Appropedia for more information.
|Health Topic||Child mortality|
|Scope||Prototype, Clinical trial|
|Location||Africa, Asia, South America|
Problem being addressed
Jaundice, caused by hyperbilirubinemia or breast milk jaundice, affects sixty percent of all newborns worldwide. It can lead to long-term disabilities or even brain damage. It is caused by factors in the breast milk which prevent the baby’s liver from processing old red blood cells correctly. Phototherapy is a cost-effective treatment for this condition.
Detailed description of the solution
Firefly is a phototherapy device has been developed specifically for resource-limited settings. It provides both top and bottom phototherapy treatment while remaining low-cost. It ensures that the treatment is effective, despite changes in the baby’s position. It is designed to be easily maintained and disinfected, reducing the chances of infection for the infants.
- Designed by: Design that Matters (DtM) and East Meets West 
- Manufacturing: This device is manufactured by MTTS and is made in Vietnam
When and where it was tested/implemented
This device has undergone clinical trials at the National OB/GYN Hospital in Hanoi, Vietnam.
Design that Matters (DtM) receives numerous funding support from the following entities: (Full listing available here.)
- Alliance for Global Sustainability
- Ashoka Foundation
- Bridgeway Charitable Foundation
- Choate Hall & Steward LLP
- DLA Piper
- Draper Richards Foundation
- MIT IDEAS Competition
- MIT Laboratory for Energy and the Environment
- MIT Media Lab
- MIT Public Service Center
- Museum of Science
- SolidWorks Corporation
- The Lynch Foundation
- Thanksgiving Fund
Internally generated reports
Project Firefly: Infant Phototherapy. (n.d.). Design that Matters. Link available here.
Externally generated reports
Firefly: SolidFly 2011 Talk. (2011). Link available here.
Firefly: Project Firefly Wins Spark Design Award. (2011). Link available here.